A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy
Clinical trial NCT00109317 · COMPLETED
Trial details
- NCT number
- NCT00109317
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Enrollment
- 686
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.